Development a Method to Extract Antibiotic Concentration From Interstitial Lung and Epithelial Lining Fluid.
NCT03970265 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2020-09-02
Summary
Infections are critical factors for the survival of critically ill patients. A serious problem is the high variability of antibiotic concentrations in critically ill patients. This may result in the risk of underdosage with possible ineffective therapeutic levels as well as in the risk of overdosage with possible adverse and toxic effects. Essential for the effectiveness of antibiotic therapy is the antibiotic concentration at target site. The goal of this study is to establish a method to extract Interstitial Lung Fluid (ILF) and Epithelial Lining Fluid (ELF) for antibiotic concentration measurements in patients following lung Transplantation and to calculate a tissue/serum concentration ratio. Improved knowledge regarding tissue penetration of Antibiotics may help to optimize drug dosing and management.
Conditions
- Lung Transplantation
Interventions
- DIAGNOSTIC_TEST
-
extraction of ELF and ILF from explanted lung tissue; meropenem concentration in ELF and ILF; ELF on postoperative day 1-5 when bronchoscopy is performed within clinical routine.
Interventions will only be performed on explanted lung tissue ex vivo and on supernatant of bronchoscopy and are therefore non-invasive
Sponsors & Collaborators
-
Ludwig-Maximilians - University of Munich
lead OTHER
Principal Investigators
-
Michael Zoller, Dr.med. · Department of Anaesthesiology, University Hospital, LMU Munich
-
Ines Schroeder, Dr.med. · Department of Anaesthesiology, University Hospital, LMU Munich
-
Mathias Brügel, Dr.med. · Institute of Laboratory Medicine, University Hospital, LMU Munich
-
Michael Vogeser, Prof.Dr.med. · Institute of Laboratory Medicine, University Hospital, LMU Munich
-
Christina Scharf, Dr.med. · Department of Anaesthesiology, University Hospital, LMU Munich
-
Uwe Liebchen, Dr.med. · Department of Anaesthesiology, University Hospital, LMU Munich
-
Eike Speck, Dr.med. · Department of Anaesthesiology of the University Hospital of Munich
-
Paal Michael, Dr.rer.nat. · Institute of Laboratory Medicine of the University Hospital of Munich
-
Alexander Indrich, Dr.med. · Department of Anaesthesiology of the University Hospital of Munich
-
Daniel Siegl, Dr.med. · Department of Anaesthesiology of the University Hospital of Munich
-
Bernhard Zwissler, Prof.Dr.med · Department of Anaesthesiology of the University Hospital of Munich
-
Daniel Teupser, Prof.Dr.med. · Institute of Laboratory Medicine of the University Hospital of Munich
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-08-15
- Primary Completion
- 2020-07-15
- Completion
- 2020-07-15
Countries
- Germany
Study Locations
More Related Trials
-
Comparative Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the ICU
NCT00307099 ·Status: TERMINATED ·Phase: PHASE3
-
Rapid Detection of Airway Pathogens for Lung Transplantation
NCT03933878 ·Status: COMPLETED
-
Study of Azithromycin for Lymphocytic Bronchiolitis/Bronchitis After Lung Transplantation
NCT01109160 ·Status: COMPLETED ·Phase: PHASE4
-
A Multi-Center Diagnostic Stewardship Program to Improve Respiratory Culture Utilization in Critically Ill Children
NCT04987840 ·Status: ENROLLING_BY_INVITATION
-
Exploratory Analysis of Pulmonary Microbiome in Intubated Patients
NCT03720093 ·Status: COMPLETED
-
Drug Resistance Factors In Healthcare-associated Pneumonia
NCT02736097 ·Status: COMPLETED
-
PCT-guided Treatment Regarding Antibiotic Use for Acute COPD Exacerbations
NCT05854901 ·Status: UNKNOWN ·Phase: NA
-
Airway Microbiome of Patients With Protracted Bacterial Bronchitis
NCT07255430 ·Status: RECRUITING
-
A Sputum Screening Test to Rule-out Pneumonia at an Early Stage
NCT03256604 ·Status: COMPLETED
-
Reducing Antimicrobial Overuse Through Targeted Therapy for Patients With Community-Acquired Pneumonia
NCT05568654 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Biomarkers for Dexamethasone Response in Sars-Cov-2 / COVID-19 Pneumonia
NCT04619693 ·Status: TERMINATED
-
Evaluation the Association of Microbiome Between Respiratory Tract Samples and Stool Samples in Pneumonic Patients Accompanied by Respiratory Failure
NCT03379779 ·Status: COMPLETED
-
Use of Compromised Lung Volume in Monitoring Usage of Steroid Therapy on Severe COVID-19
NCT04953247 ·Status: COMPLETED
-
CRP-guided Antibiotic Treatment in COPD Exacerbations Admitted to the Hospital
NCT01232140 ·Status: UNKNOWN ·Phase: NA
-
Biodistribution and Dosimetry Evaluation of [124I]FIAU
NCT01337466 ·Status: COMPLETED ·Phase: PHASE1
-
Local Antibiotic Delivery for Community Acquired Pneumonia
NCT06859450 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Comparison of IgA Levels in the Bronchoalveolar Lavage Fluid of Patients With and Without Antibiotic Therapy
NCT02912520 ·Status: COMPLETED
-
Azithromycin in Bronchiolitis Obliterans Syndrome
NCT01009619 ·Status: COMPLETED ·Phase: PHASE4
-
Investigating the Impact of Sepsis Phenotypes on Antibiotic Treatment in Patients With Severe Pneumonia and Sepsis
NCT06977165 ·Status: NOT_YET_RECRUITING
-
Pneumococcal Carriage in Patients With Lower Respiratory Tract Infection (LRTI)
NCT01861184 ·Status: COMPLETED
-
Diagnostic and Prognostic Value of Lung Microbiota in Early Lung Infection After Lung Transplantation
NCT05627505 ·Status: UNKNOWN
-
Diagnostic Breath Analysis for Detection of Ventilator Acquired Pneumonia (VAP)
NCT03053258 ·Status: COMPLETED
-
Assessment of the Effectiveness of a Prototype Diagnostic System of Bacterial Respiratory Infections Based on Real-time Sequencing
NCT07303400 ·Status: ACTIVE_NOT_RECRUITING
-
Study of Leukocyte Immunophenotype and the Lipid Transport System as Predictive Biomarkers of Severe Bacterial Infections
NCT04178915 ·Status: ENROLLING_BY_INVITATION
-
Accuracy of Lung Injury Biomarkers in the Initial Investigation of Patients With Suspected Pneumonia
NCT04686331 ·Status: COMPLETED